Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
07 feb 2011 - 07:40
Statutaire naam
Crucell N.V.
Titel
Crucell Reports Fourth Quarter and Full Year 2010 Results
Bericht
Crucell Reports Fourth Quarter and Full Year 2010 Results
Total revenues and other operating income of €365.4 million for the
full year 2010 compared to €358.0 million in 2009.
Due to write-downs of Quinvaxem® inventory and higher operating expenses, operating loss for the year was €34.3 million compared to €39.0 million operating profit in 2009. The year ended with a net loss of €27.6 million compared to €23.9 million net profit in the previous year and
undiluted EPS of minus €0.34 compared to €0.34 in 2009.
Datum laatste update: 01 september 2024